IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q3 2024 Holdings

Filed 2024-11-13 | 11 holdings | $168.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$73.1M639,53943.4%
Inozyme Pharma IncCOM45790W108$23.5M4,494,85114.0%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$19.7M2,120,50811.7%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$19.6M1,595,91811.6%
Zenas Biopharma Inc(ZBIO)COM98937L105$11.0M650,6956.5%
Bioage Labs Inc(BIOA)COM09077V100$11.0M527,6476.5%
Exscientia PLCADS30223G102$3.8M770,5002.2%
Rallybio CorpCOM75120L100$2.8M2,404,6441.7%
Vigil Neuroscience Inc(VIGL)COM92673K108$1.9M560,5951.1%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$1.2M1,891,4670.7%
IO Biotech Inc(IOBT)COM449778109$907.4K864,1970.5%